Leading the Way in Life Science Technologies

GEN Exclusives

More »

Columns

More »

For full access to this article login to GEN Select now.

September 01, 2015 (Vol. 35, No. 15)

Repligen Now a Bioprocess Product Firm

One-Time Therapeutics Player Bets Future on Working as Supplier to Bioprocess Companies

  • Repligen, once a strongly focused therapeutics firm, has transformed itself into a bioprocess products company in only a few years’ time. As the company’s former COO Tony J. Hunt takes the helm as president and CEO after the May retirement of Walter C. Herlihy, Ph.D., that transformation will continue ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.